27 min listen
Dual Antiplatelet Therapy After Acute Coronary Syndrome
Dual Antiplatelet Therapy After Acute Coronary Syndrome
ratings:
Length:
24 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
Dual antiplatelet therapy, typically aspirin and an oral P2Y12 receptor inhibitor (clopidogrel, prasugrel, ticagrelor, cangrelor), reduces adverse events after acute coronary syndrome (ACS) but choice of agent and optimal duration may be patient-specific. Umair Khalid, MD, a cardiologist at the Baylor School of Medicine in Houston, discusses how to use these agents in management of ACS. Related Article(s): Oral Antiplatelet Therapy After Acute Coronary Syndrome
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (100)
Treating Geriatric Polypharmacy by Deintensifying Unnecessary Diabetes Treatment: Polypharmacy is a rapidly worsening problem that hits elderly patients particularly hard. As patients grow older, they need more medications but at the same time become less capable of managing the complexity of drug treatments. In order... by JAMA Clinical Reviews